From penicillin in 1928 to DNA in the 1950s and monoclonal antibodies in 2002, the UK’s life sciences and health technology sector continues to lead the world. In recent years the rapid growth in medtech has seen exciting innovations in diagnostics, instrumentation and medical devices; and the constant delivery of ground-breaking sciences and cutting-edge products developed by UK companies benefits the lives of billions across the globe.
From pharma to biotech, medical devices and diagnostics to the next generation of digitally enabled healthcare, we partner with clients across the whole market spectrum. Our deep understanding of hiring leaders into these environments, and of the challenges facing a scaling company, puts us in an ideal position to help you build your executive or non-executive team. From executive, commercial and operational functions to research and clinical development activities, we are able to identify the right leaders to help your business to scale.
We can get involved at any time after seed investment, right through to Series C and beyond. Many of the companies we work with are referred by VC houses: a business may need a leadership refresh or an entirely different skillset in order to grow.
Building the future
Much of technology begins in the start-ups, universities and accelerators around the UK – powered by venture funding and leaning on our ecosystem to take their products through the development process. With record-breaking investment year on year, the UK is entering a golden age of life sciences and health technology – and at Bailey Fisher we seek to support these fast-growth companies as they build the leadership teams they need to disrupt the market.